Hjem › Gastrointestinale kræftformer › Californien
Gastrointestinale kræftformer kliniske forsøg i Californien
28 studier for Gastrointestinale kræftformer søger deltagere på steder i Californien.
Byer i Californien
- Los Angeles9 studier
- Baldwin Park7 studier
- San Francisco5 studier
- San Diego4 studier
- Mountain View4 studier
- Sacramento4 studier
- Santa Monica4 studier
- Orange3 studier
Officiel studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- og 8 flere
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07283939Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07529808A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- UCSF at Berkeley Outpatient Center, Berkeley
- Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
- UCSD Medical Center - Encinitas, Encinitas
- og 21 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07222800DESTINY-PANTUMOUR04
- Research Site, San Diego
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Duarte
- GSK Investigational Site, La Jolla
- GSK Investigational Site, Los Angeles
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07218926Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- UC San Diego Moores Cancer Center, La Jolla
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Hematology/Oncology- Santa Monica, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06445062Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
- Stanford Cancer Center, Palo Alto
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05274048Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- University of California, San Francisco, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT06633224Personalized Health Self-Management Training for Colorectal Cancer Survivors
- University of Southern California, Los Angeles
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05984589Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT06582017A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- City of Hope, Duarte
- Hoag Memorial Hospital Presbyterian, Newport Beach
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT07544589Understanding New Cachexia Subtypes Through Observational Epidemiological Research
- Kaiser Permanente Northern California, Pleasanton
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT07776353Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- University of California, San Francisco, San Francisco
- John Muir Medical Center-Walnut Creek, Walnut Creek
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT04221893A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Los Alamitos
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Santa Monica
- og 1 flere
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT06885034A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- City of Hope Nat Medical Ctr, Duarte
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07224750A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 7. jul. 2026 · NCT07337525Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- University of California, Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- St Joseph Heritage Healthcare, Santa Rosa
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
- UCLA, Santa Monica
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT05379985A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. apr. 2026 · NCT07020221Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
- Interventional Endoscopy Services, San Francisco
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 23. mar. 2026 · NCT01750619PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
RekruttererTidlig fase 1
Alder 18 og opefter · Alle køn · Opdateret 27. feb. 2026 · NCT06511037Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
- Cedars-Sinai Medical Center, Los Angeles
Rekrutterer
Alder 18 til 99 · Alle køn · Opdateret 20. feb. 2026 · NCT04907643Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
- Cedars-Sinai Medical Center, Los Angeles
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2025 · NCT07124351Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- City Of Hope, Duarte
- Stanford Cancer Center, Palo Alto
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 15. aug. 2025 · NCT05406167Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
- City of Hope, Duarte
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2023 · NCT06002425Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.